HomeCompareTFINP vs MRK

TFINP vs MRK: Dividend Comparison 2026

TFINP yields 8.00% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TFINP wins by $31963.30M in total portfolio value
10 years
TFINP
TFINP
● Live price
8.00%
Share price
$22.25
Annual div
$1.78
5Y div CAGR
94.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31963.36M
Annual income
$30,985,592,821.15
Full TFINP calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — TFINP vs MRK

📍 TFINP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTFINPMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TFINP + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TFINP pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TFINP
Annual income on $10K today (after 15% tax)
$680.38/yr
After 10yr DRIP, annual income (after tax)
$26,337,753,897.98/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, TFINP beats the other by $26,337,745,569.57/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TFINP + MRK for your $10,000?

TFINP: 50%MRK: 50%
100% MRK50/50100% TFINP
Portfolio after 10yr
$15981.71M
Annual income
$15,492,801,309.64/yr
Blended yield
96.94%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

TFINP
Analyst Ratings
3
Buy
6
Hold
1
Sell
Consensus: Hold
Altman Z
0.3
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TFINP buys
0
MRK buys
0
No recent congressional trades found for TFINP or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTFINPMRK
Forward yield8.00%2.76%
Annual dividend / share$1.78$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR94.6%32.7%
Portfolio after 10y$31963.36M$56.8K
Annual income after 10y$30,985,592,821.15$9,798.13
Total dividends collected$31895.79M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: TFINP vs MRK ($10,000, DRIP)

YearTFINP PortfolioTFINP Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$12,258$1,557.67$11,206$366.19+$1.1KTFINP
2$16,588$3,472.51$12,650$502.35+$3.9KTFINP
3$26,296$8,546.63$14,407$694.19+$11.9KTFINP
4$52,777$24,640.19$16,585$967.82+$36.2KTFINP
5$146,412$89,940.89$19,342$1,363.89+$127.1KTFINP
6$610,445$453,784.18$22,913$1,947.19+$587.5KTFINP
7$4,094,122$3,440,945.63$27,662$2,823.89+$4.07MTFINP
8$46,351,867$41,971,156.23$34,159$4,173.35+$46.32MTFINP
9$913,800,824$864,204,326.32$43,337$6,308.80+$913.76MTFINP
10$31,963,359,703$30,985,592,821.15$56,776$9,798.13+$31963.30MTFINP

TFINP vs MRK: Complete Analysis 2026

TFINPStock

Triumph Financial Inc., a financial and technology company, focuses on payments, factoring, and banking. It operates through a portfolio of brands, including TriumphPay, Triumph, and TBK Bank. The company offers cash flow management services for the trucking industry comprising invoice factoring, fuel discount programs, truck and cargo insurance, and equipment finance, banking, and treasury services. It also provides factoring products and services; insurance products and services; and equipment finance and asset based lending products and services. The company was formerly known as Triumph Bancorp, Inc. and changed its name to Triumph Financial Inc. in December 2022. Triumph Financial Inc. was founded in 1981 and is headquartered in Dallas, Texas.

Full TFINP Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this TFINP vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TFINP vs SCHDTFINP vs JEPITFINP vs OTFINP vs KOTFINP vs MAINTFINP vs JNJTFINP vs ABBVTFINP vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.